Wheel alternatives

Tessic Health is the best Wheel alternative in 2026 for a brand that wants the clinic operated rather than clinicians handed over through an API: licensed providers in all 50 states credentialed under the client's brand, with pharmacy, labs, billing, and compliance included and the pricing published. Wheel publishes no rate card, no per-consult fee, and no medication markup as of September 4, 2026, so a brand learns its unit economics only after a procurement cycle. OpenLoop, Beluga Health, Telegra, CareValidate, Fuse Health, and MyTelemedicine are the other alternatives. The decision turns on what each publishes, how much of the platform arrives operated, and how fast a brand can sell.

Wheel is a capable company aimed at a specific buyer. Founded in 2018 in Austin, it reports more than $216 million raised, 7 million patient visits, and 70 or more care programs on its Wheel Horizon platform, sold to health plans, pharma, retailers, and third-party administrators. That is an enterprise motion: a configurable platform, implementation engineers, and pricing quoted deal by deal.

For a founder-led consumer brand, two things break. Nothing is published, so margin per patient cannot be modeled before a sales cycle, and medication economics and any revenue share stay unstated as of September 4, 2026. And the shape is wrong: Wheel supplies clinicians and software for a product team to integrate, while a consumer brand needs the storefront, the pharmacy, the billing, and the compliance structure already running.

OpenLoop is the closest thing to Wheel's breadth outside the enterprise tier: a white-label operating system with a provider network across 35 or more specialties, a 50-state professional corporation network with NCQA-certified credentialing, a pharmacy and lab network, a payer network of more than 600 plans, and a Launchpad tool that builds a storefront in as little as 24 hours.

The catch is the money path. In the written proposal set out line by line on the Tessic Health vs OpenLoop comparison page, patients pay into OpenLoop's merchant account, the brand is remitted weekly, and OpenLoop retains 50 to 59 percent of what a maintenance patient pays, on a 12-month initial term, as of September 4, 2026. For a payer-billed or health-system program that breadth can still be worth it. For a cash-pay subscription brand it is the most expensive line in the model.

Telegra is the storefront-first option for a buyer who wants a monthly number to budget against. Its plans run roughly $3,000 to $6,000 a month plus a one-time onboarding fee and separate per-consult fees, per mid-2026 roundups checked against its site, with licensed providers in all 50 states and prescribing and pharmacy routing under the brand's name.

That base costs more than Tessic Health's $1,000 or $2,000 platform fee before a single patient, and the gap widens with volume, because Tessic's variable cost is a flat $25 consult with medication at 0% markup. Telegra scopes launches in weeks per vertical, and its scope centers on the visit and prescription layer rather than an operated clinic.

Fuse Health is purpose-built for compounded peptides: intake, formularies, and follow-up workflows structured for that vertical, licensed providers in all 50 states, async review, routing to accredited compounding pharmacies, and either a pre-built branded storefront or a medical API for teams that want their own front end.

Its published pricing lists monthly tiers of $299, $699, and $3,000, a merchant service fee on every sale of 10 percent on the entry tier and 2 percent above it, and per-consult fees of $20 async and $35 sync, as of September 4, 2026. That percentage grows with the brand, and Fuse markets no dedicated GLP-1 program and does not publicly describe an MSO structure, so a brand adding hormone therapy will outgrow it.

Wheel is the right answer for a real set of buyers, and none of them is a founder-led consumer brand. A health plan, a pharma program, a national retailer, or a third-party administrator is the buyer Wheel sells to directly, and it has the resume to clear security review and procurement: more than $216 million raised and 7 million patient visits reported on its site. A product team that wants to embed clinicians in software it already owns will find Wheel's API-first deployment is exactly that shape, and Tessic Health's hosted model is not.

Two more cases hold. A catalog of 70 or more care programs suits an enterprise standing up several care lines on one contract, and the Amazon Pharmacy integration is a fulfillment story procurement already trusts. The boundary: if the ask is breadth, integration, and an enterprise contract, stay with Wheel. If the ask is a branded cash-pay clinic with published economics and a launch in days, that is a different product.